Biological Information
Background Information:
Foretinib (GSK1363089) is a synthetic small anticancer molecule. Potently and ATP-competitively inhibits MET and VEGFR2 (IC50=0.4 and 0.9nM, respectively), kinase enzymes believed to promote tumor growth and angiogenesis. Previously underwent clinical trials for breast cancer and NSCLC but no product made it to market. Provided as 5 mg of dry powder.
Usage
Product Type:
Control Ligands & Inhibitors
Application:
Drug Discovery & Development
Storage Conditions:
Store at -20°C. Please avoid multiple freeze/thaw cycles.
Usage disclaimer:
These products may be covered by issued US and/or foreign patents, patent applications and subject to a Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.
Additional Information
Brand:
Eurofins DiscoverX®